# Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg

> **Open Intelligence Dossier** · First detected: 2026-08-26 04:07 UTC · Category: Business

## Executive Summary
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg" is generating significant coverage in the Business category, with 6 articles from 6 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Seeking Alpha, The Business Journals, Fierce Pharma and BioPharma Dive. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Seeking Alpha | Bristol Myers Squibb exits Cellares pact (BMY:NYSE) | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxNTExOcXlFbEJIOC1xQ3lqdmlTdGNTM3NfcFVYQkpQRkNJdXZPeDJvbEt4WS1ic3NzSEFZQ2ZJVHd6Q2dYem9zalc4WUdETlJBX200TVRVWUdMMDIxY1hDejc0aVJ3clQ0OENzbkpGTjdEUWFCR244QlI1Y2hZVVFMYWpOeXU?oc=5) |
| The Business Journals | Fast-growing biotech startup Cellares plans layoffs after losing major customer | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxQaC1Xb3ZWeVlEUFhiVTNxVDRnLWUzamQwbmNrdXVuYTdzMHpQZS1wUzVkNmM3OW9uU2w1RHNyXzNfSVJLWWpOYUlfdHB2Ukc1SnpycUZ1STlrRUhjQkdrVFFKSDFoM1A0b3U2OElWdXMtdmFmcnRiT1N2bXlXYmM0a1VHSnJ1dFZlNjAxc0N3NWZjXzJEaDhRNUZpTXJBNWdTUmVNczBTQm43a09STEUtR2lR?oc=5) |
| Fierce Pharma | Cellares CEO seeks to 'resize' company after loss of 'large' cell therapy manufacturing customer | [Source Link](https://news.google.com/rss/articles/CBMivwFBVV95cUxOVmxWVExZWHB2RzRyRnF4M3NmME1iRkZ0MDNqNFdaZXFNbXZMcExKTXl6SUQ4dklCZnY0ZS1jZHo4Mks1N1o1d2RPem8tcjdVZ3hRWEd1cUktRFpUSlVxdEdOOWFNaFNtYzVraVA1NDgzUjlwbUlHQ2pDd1dZckxOV01jV09QMlZ4NXdlMnNSZGIyRG9JcnE0eDR6R0Z6elhZNk9jOUpsaHc3R2xNcGJ1bXJxZC1yS1JfWUg3TzhIcw?oc=5) |
| BioPharma Dive | Cellares, a cell therapy manufacturing specialist, to lay off 100 employees | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxQRnhmam05azZaN2UzVEtKTUthM3VXeEU3dnZtaVJIVzQ3ekhfNTVfaGhsTHBPQWRQQUh3VmpCV2F0NWhRRzZ4aDIyVFhMSkF5ZWdHMlNGNERXU2ZsMlA1MGJhQ1Z1ekhVN3YzS3k1dmxpRzVCMWR3Z2lUdWxoWC1JZlIxaEhZMFdrNFIyVHNwNA?oc=5) |
| Reuters | Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares | [Source Link](https://news.google.com/rss/articles/CBMixgFBVV95cUxQblFOZVZ1VkVaUFlZTURQRmJGMFpQNnhBTjRmWGlXU3M0ekx1UEoxUFFhNGxic3EzOFNtTTVCNE9DeU4xakhsQWVZZUhWNkdnUmIxakF5TlZiN1VsLTVYTTlMbllsZXBMYTJFM2lDdDhONVV3NWVlSWp1dHB5N25hQXRfYjZBTHRWeG5tUjBHYnQ1QWU3WFRSOFEwODVhazV6NXRfLTZJTmNPN19iTG9KcjVMREl5UWpwN01vekVacGNleVJtclE?oc=5) |
| Endpoints News | Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxOVEFHUGU0aUtETVNwdDdTZDJ3a1Y5WjVVOHZKZVQtUU5vNlZEeEtjNHRWaVdpNF9Da0JjRXdZbW9Sc2YxUXQtZmpiYXFBVU5GVnl6ZkpiY2tnMUFGdWlXeDdiQXc3U2hoVjVPNkFPbjVUZTJRQ1pwN3B2YmRhS1ZLMm9IR0tfNkJNTmdtRmtacVlSbVFINjBCUE1waEM?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-08-26/bristol-myers-ends-deal-with-cellares-cell-therapy-manufacturer-to-reorg*